<https://rdf.molmedb.upol.cz/reference/ref1704> <http://purl.org/ontology/bibo/pmid> "23769168"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmc.2013.05.025"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J.: Novel triple reuptake inhibitors with low risk of CAD associated liabilities: design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds. Bioorg Med Chem, Volume 21 (15), 2013"^^<http://www.w3.org/2001/XMLSchema#string> .
